TRV GP II, LLC

Holdings History for JOUNCE THERAPEUTICS INC - COM (JNCE)

Symbol: JNCE
Investment type: Equity / COM

Shares, Excluding Options vs Price

Value, Excluding Options

Holdings date	Weight	Change	Value $	Shares	Change	Activity %	Price	All Holders
30 Sep 2022	100%	-135%	$1,340,000	572,829	-775,000	-57%	$2.34	Q3 2022
30 Jun 2022	88%	0%	$4,084,000	1,347,829	0		$3.03	Q2 2022
31 Mar 2022	93%	-94%	$9,152,000	1,347,829	-1,350,000	-50%	$6.79	Q1 2022
31 Dec 2021	93%	0%	$22,527,000	2,697,829	0		$8.35	Q4 2021
30 Sep 2021	89%	-58%	$20,045,000	2,697,829	-1,750,000	-39%	$7.43	Q3 2021
30 Jun 2021	89%	-41%	$30,245,000	4,447,829	-2,052,520	-32%	$6.80	Q2 2021
31 Mar 2021	42%	-18%	$66,759,000	6,500,349	-2,700,000	-29%	$10.27	Q1 2021
31 Dec 2020	45%	-5%	$64,402,000	9,200,349	-1,030,000	-10%	$7.00	Q4 2020
30 Sep 2020	54%	0%	$83,480,000	10,230,349	0		$8.16	Q3 2020
30 Jun 2020	52%	0%	$70,589,000	10,230,349	0		$6.90	Q2 2020
31 Mar 2020	52%	0%	$48,594,000	10,230,349	0		$4.75	Q1 2020
31 Dec 2019	92%	0%	$89,311,000	10,230,349	0		$8.73	Q4 2019
30 Sep 2019	76%	0%	$34,067,000	10,230,349	0		$3.33	Q3 2019
30 Jun 2019	82%	0%	$50,640,000	10,230,349	0		$4.95	Q2 2019
31 Mar 2019	41%	0%	$63,428,000	10,230,349	0		$6.20	Q1 2019
31 Dec 2018	34%	0%	$34,476,000	10,230,349	0		$3.37	Q4 2018
30 Sep 2018	39%	0%	$66,497,000	10,230,349	0		$6.50	Q3 2018
30 Jun 2018	44%	0%	$78,364,000	10,230,349	0		$7.66	Q2 2018
31 Mar 2018	76%	0%	$228,648	10,230,349	0		$0.02	Q1 2018
31 Dec 2017	23%	0%	$130,437,000	10,230,349	0		$12.75	Q4 2017

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.